What is Environmentally Acquired Illness?
In today’s industrialized world, we are constantly exposed to an unprecedented array of environmental toxins. From the air we breathe to the products we use daily, our bodies face a chemical onslaught that can gradually undermine our health. Environmentally Acquired Illness (EAI) represents a growing health concern that remains largely unrecognized within conventional medicine, despite mounting evidence of its impact on millions of lives worldwide.
Understanding Environmentally Acquired Illness
Environmentally Acquired Illness refers to a spectrum of health conditions triggered or exacerbated by exposure to environmental toxins and pathogens. EAI develops from air and water pollution, persistent infections, toxins in food and sensitivity to electromagnetic fields. Symptoms can range from mild discomfort to severe debilitation.
Primary Causes of EAI
- Mold and Mycotoxin Exposure: Toxic mold species like Stachybotrys, Aspergillus, and Chaetomium produce potent biotoxins that can severely impact neurological, immune, and respiratory function[1][2]
- Persistent Infections: Including tick-borne diseases (Lyme disease, Babesia, Bartonella, Ehrlichia), opportunistic viral infections (EBV, HHV-6, CMV, SARS-COV-2), and parasitic infections[3][4]
- Chemical Toxicants: Including pesticides, herbicides, industrial solvents, flame retardants, and plasticizers (phthalates and BPA)[5][6]
- Heavy Metals: Particularly mercury, lead, arsenic, cadmium, and aluminum from various industrial, environmental, and consumer sources[7][8]
- Air Pollution: Particulate matter, nitrogen oxides, ozone, sulfur dioxide, and volatile organic compounds (VOCs)[9][10]
- Water Contaminants: Including chlorine byproducts, fluoride, agricultural runoff, pharmaceutical residues, and PFAS (“forever chemicals”)[11][12]
Lesser-Known Common Contributors to EAI
- Electromagnetic Fields (EMF): Increasing evidence suggests sensitivity to wireless technology emissions, particularly in electromagnetically hypersensitive individuals[13][14]
- Microplastics: These increasingly ubiquitous particles have been found in human blood, placentas, and organs with emerging concerns about their biological impacts[15][16]
- Dental Materials: Mercury amalgams, nickel, palladium, and composite materials that can leach compounds or trigger immune reactions[17][18]
- Cosmetic and Personal Care Ingredients: Parabens, sodium lauryl sulfate, synthetic fragrance compounds, and other additives with potential hormone-disrupting properties[19][20]
- Food-Related Chemicals: Artificial colors, preservatives, flavor enhancers, pesticide residues, and processing additives[21][22]
- Building Materials: Formaldehyde, flame retardants, VOCs from adhesives, sealants, insulation, and treated wood products[23][24]
- Silica Dust: From construction sites, manufacturing, and natural sources, potentially triggering inflammatory responses[25]
- Office Equipment Emissions: Toner particles and other compounds released from printers, copiers, and electronics[26]
- Pharmaceutical Residues: Both in water supplies and as direct exposures through medication side effects or adverse reactions[27]
- Noise Pollution: Emerging research suggests chronic noise exposure triggers stress responses with physiological consequences[28]
This extensive range of potential exposures illustrates why EAI presents so diversely among affected individuals and why a comprehensive approach to identification and treatment is essential.
What makes EAI particularly insidious is its often gradual onset and the difficulty in establishing clear causal relationships between exposures and symptoms. This challenge is compounded by the fact that each individual’s tolerance threshold and reaction to toxins can vary dramatically based on genetic predispositions, overall toxic burden, and the status of their immune system.
The Widespread Yet Invisible Epidemic
Millions of people report adverse health effects when exposed to common environmental substances. New furniture releases formaldehyde and other volatile organic compounds (VOCs). Fresh carpet outgasses dozens of chemicals. Even clothing treated with flame retardants, antimicrobials, or wrinkle-resistant chemicals can trigger reactions in sensitive individuals. More concerning are the lower-level chronic exposures from everyday products—cleaning supplies, personal care items, and synthetic fragrances found in everything from laundry detergent and fabric softeners to shampoo, soap, and deodorant.
The ubiquity of these exposures makes EAI both widespread and difficult to escape. Consider that synthetic fragrances alone—which can contain hundreds of undisclosed chemicals—are present in virtually every commercial space and most homes. For those with heightened sensitivity, this creates an invisible minefield in daily life.
Why EAI Remains Underrecognized
Despite its prevalence, EAI remains underestimated as a contributing factor to chronic illness for several critical reasons:
1. Medical Education Gaps
Conventional medical training devotes minimal attention to environmental medicine. Most physicians receive less than seven hours of training in environmental health during their entire medical education. This knowledge gap leaves doctors ill-equipped to recognize the patterns of environmental illness or understand the mechanisms by which toxins affect biological systems.
2. Diagnostic Challenges
EAI often presents with multisystem, nonspecific symptoms that don’t fit neatly into established diagnostic categories. Patients might experience fatigue, cognitive difficulties, joint pain, digestive issues, and neurological symptoms simultaneously. This pattern frequently leads to misdiagnosis or dismissal as psychosomatic illness.
3. Limited Testing Options
Conventional medical testing rarely includes environmental toxin assessments. Standard blood tests fail to detect many environmental toxins, especially those that have already moved from circulation into tissue storage. Without specialized testing, the connection between symptoms and exposures remains obscured.
4. The Complexity of Multiple Exposures
Most research examines single toxins in isolation, but real-world exposures involve complex mixtures. The synergistic effects of multiple toxins—how they interact and potentially amplify each other’s impact—remains poorly understood and largely unstudied.
5. Industry Influence
The chemical, pharmaceutical, and agriculture industries wield significant influence over regulatory frameworks and research priorities. This has historically slowed recognition of health impacts from various environmental exposures and delayed protective regulations.
The Biological Mechanisms of EAI
While EAI isn’t broadly recognized as a formal diagnosis in conventional healthcare, the biological mechanisms underlying environmental illness are increasingly well-documented. These mechanisms help explain how environmental exposures can trigger recognized conditions like mast cell activation syndrome, allergic asthma, autoimmune disorders, and neurological dysfunction. Understanding these pathways is crucial for developing effective interventions and prevention strategies.
Oxidative Stress and Inflammation
Environmental toxins frequently generate oxidative stress—an imbalance between free radicals and antioxidants that can damage cells, proteins, and DNA. This oxidative damage triggers inflammatory cascades that, when chronic, contribute to tissue degradation and dysfunction across multiple body systems.
Immune Dysregulation
Many environmental toxins are immunomodulatory, meaning they can disrupt normal immune function. This disruption may manifest as hyperreactivity (as in chemical sensitivity or Mast Cell Activation Syndrome), immunosuppression (increasing susceptibility to infections), or autoimmunity and cancers (where there is a failure of immune surveillance. Research has shown that toxic exposures can alter T-cell function, cytokine production, and antigen recognition, fundamentally changing how the immune system operates.
Mast Cell Activation
A particularly important mechanism in EAI involves mast cells—immune sentinels that release histamine and other inflammatory mediators in response to threats. Environmental toxins can trigger abnormal mast cell degranulation, leading to Mast Cell Activation Syndrome (MCAS), characterized by multi-system inflammatory responses. MCAS represents one of the more recognized manifestations of environmental illness in naturopathic and functional medicine, though its environmental triggers are often overlooked.
Mitochondrial Damage
The mitochondria—our cellular energy powerhouses—are particularly vulnerable to environmental toxins. Pesticides, heavy metals, and certain biotoxins signal the mitochondria to reduce energy production, contributing to the profound fatigue characteristic of many environmentally acquired illnesses.[29][30] This reduction in energy occurs through several mitochondrial mechanisms:
- Toxins disrupt the flow of nutrients into the mitochondria
- Mitochondria respond by decreasing their production of ATP
- Inhibition of electron transport chain complexes
- Disruption of membrane integrity
- Increased oxidative damage to mitochondrial DNA
- Impaired mitochondrial protein synthesis
- Dysregulation of mitochondrial dynamics (fusion and fission)
The resulting cellular energy crisis affects high-energy-demand tissues first, including the brain, heart, muscles, and endocrine system, explaining the characteristic neurological and systemic symptoms of many environmentally acquired illnesses.[31]
Genetic Expression Alterations
Environmental exposures can trigger epigenetic changes—modifications that affect gene expression without altering the underlying DNA sequence.[32][33] These changes can persist long after the initial exposure has ended, potentially explaining the chronic nature of many environmentally-linked conditions.
EAI and Complex Chronic Illness
The relationship between environmental exposures and complex chronic illnesses offers a critical perspective often missing from conventional approaches to conditions like:
- Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
- Fibromyalgia
- Multiple Chemical Sensitivity
- Chronic Lyme Disease
- Long COVID
- Chronic Inflammatory Response Syndrome (CIRS)
- Certain autoimmune disorders
- Neurological conditions, including some cases of Parkinson’s disease
- Irritable Bowel Syndrome and other functional gastrointestinal disorders
- Postural Orthostatic Tachycardia Syndrome (POTS)
- Small Fiber Neuropathy
- Chronic pain syndromes
- Dysautonomia
- Ehlers-Danlos Syndrome (environmental factors may worsen symptoms)
In many cases, environmental exposures may serve as initiating triggers, contribute to ongoing dysfunction, or prevent recovery despite other interventions. Understanding this connection provides new avenues for both prevention and treatment.
The Total Load Concept
A crucial aspect of understanding EAI is the “total load” concept—the cumulative burden of stressors that ultimately overwhelms an individual’s adaptive capacity.[34][35] This explains why:
- Symptoms often appear after a lifetime of low-level exposures, which reach a tipping point
- Seemingly minor exposures can trigger severe reactions in already-burdened individuals
- Addressing only one aspect of exposure often yields limited results
- Recovery typically requires a comprehensive approach to reducing total toxic burden
This model helps explain why conventional medicine, with its focus on addressing single diagnoses rather than systemic contributors, often falls short in recognizing and treating environmentally acquired illnesses.
Moving Toward Recognition and Solutions
Progress in addressing EAI requires a multi-faceted approach:
- Enhanced Medical Education: Integrating robust environmental health training into medical school curricula and continuing education.
- Improved Diagnostic Tools: Developing and validating accessible, reliable testing methods for environmental exposures and their biological effects.
- Personalized Medicine Approaches: Recognizing individual susceptibilities based on genetic variations, detoxification capacity, and pre-existing conditions.
- Regulatory Reform: Strengthening protections against harmful substances, particularly emphasizing the precautionary principle—that chemicals should be proven safe before widespread use rather than proven harmful after exposure.
- Public Awareness: Educating consumers about potential environmental hazards and practical steps to reduce exposure in daily life.
Practical Steps for Individuals
While systemic change is essential, individuals can take several steps to reduce their environmental toxic burden:
- Air Quality Improvement: Using high-quality HEPA and activated carbon filtration in homes and workplaces
- Water Filtration: Installing comprehensive water filtration systems to remove contaminants
- Clean Diet Emphasis: Prioritizing organic foods and minimizing processed food consumption
- Personal Care Product Review: Switching to toxin-free alternatives for cosmetics, cleaning products, and personal care items
- EMF Reduction: Minimizing unnecessary wireless exposure, particularly during sleep
- Mold Remediation: Properly addressing water damage and mold growth in buildings
- Detoxification Support: Optimizing natural detoxification pathways through hydration, nutrition, movement, and targeted supplementation when appropriate
- Stress Management: Recognizing that psychological stress further burdens physiological resilience
For those already experiencing symptoms of environmentally acquired illness, working with clinicians trained in environmental medicine or naturopathic and functional medicine approaches may provide more comprehensive assessment and treatment options than conventional care alone.
The Environment’s Effect on Biology
Environmentally Acquired Illness represents a critical but underappreciated factor in the growing epidemic of chronic disease. The disconnect between environmental exposures and chronic symptoms leads to misdiagnosis, ineffective treatments, and unnecessary suffering for millions. By acknowledging the role of our environment in health and disease, we open new pathways to understanding, preventing, and addressing complex chronic illnesses that have thus far resisted conventional approaches.[36]
As research continues to illuminate the mechanisms by which our surroundings affect our biology, the medical paradigm must evolve to incorporate this knowledge. Recognizing EAI isn’t just about adding another diagnostic category—it’s about fundamentally reimagining our approach to chronic illness through the lens of our ongoing relationship with our environment. For patients suffering from unexplained chronic conditions, this perspective may finally offer the validation, understanding, and effective interventions they’ve long been seeking.
Curious about becoming a patient with Gordon Medical?
The first step is to schedule a Discovery Call. This is an opportunity for you to speak with a New Patient Coordinator who can help answer many of the questions you have about working with us. They’ll review the process, cost, and help guide you to the practitioner who is best suited for your care.
Join us at the Gordon Medical Forum for events, workshops, and webinars with medicine’s most innovative minds. Gain exclusive access to groundbreaking conversations, insights, and solutions from leading pioneers in chronic illness treatment.
Sign up for updates and learn more at www.gordonmedicalforum.com
References
[1] Shoemaker RC, House D, Ryan JC. (2014). Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant. Neurotoxicology and Teratology, 45, 18-26.
[2] Hope J. (2013). A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. The Scientific World Journal, 2013, 767482.
[3] Koedel U, Fingerle V, Pfister HW. (2015). Lyme neuroborreliosis-epidemiology, diagnosis and management. Nature Reviews Neurology, 11(8), 446-456.
[4] Steere AC, Strle F, Wormser GP, et al. (2016). Lyme borreliosis. Nature Reviews Disease Primers, 2, 16090.
[5] Mostafalou S, Abdollahi M. (2017). Pesticides: an update of human exposure and toxicity. Archives of Toxicology, 91(2), 549-599.
[6] Gore AC, Chappell VA, Fenton SE, et al. (2015). EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews, 36(6), E1-E150.
[7] Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. (2012). Heavy metal toxicity and the environment. Experientia Supplementum, 101, 133-164.
[8] Bjørklund G, Dadar M, Mutter J, Aaseth J. (2017). The toxicology of mercury: Current research and emerging trends. Environmental Research, 159, 545-554.
[9] Kelly FJ, Fussell JC. (2015). Air pollution and public health: emerging hazards and improved understanding of risk. Environmental Geochemistry and Health, 37(4), 631-649.
[10] Pope CA 3rd, Dockery DW. (2006). Health effects of fine particulate air pollution: lines that connect. Journal of the Air & Waste Management Association, 56(6), 709-742.
[11] Villanueva CM, Cordier S, Font-Ribera L, et al. (2015). Overview of disinfection by-products and associated health effects. Current Environmental Health Reports, 2(1), 107-115.
[12] Lindstrom AB, Strynar MJ, Libelo EL. (2011). Polyfluorinated compounds: past, present, and future. Environmental Science & Technology, 45(19), 7954-7961.
[13] Belpomme D, Hardell L, Belyaev I, et al. (2018). Thermal and non-thermal health effects of low intensity non-ionizing radiation: An international perspective. Environmental Pollution, 242(Pt A), 643-658.
[14] Heuser G, Heuser SA. (2017). Functional brain MRI in patients complaining of electrohypersensitivity after long term exposure to electromagnetic fields. Reviews on Environmental Health, 32(3), 291-299.
[15] Leslie HA, van Velzen MJM, Brandsma SH, et al. (2022). Discovery and quantification of plastic particle pollution in human blood. Environment International, 163, 107199.
[16] Ragusa A, Svelato A, Santacroce C, et al. (2021). Plasticenta: First evidence of microplastics in human placenta. Environment International, 146, 106274.
[17] Mutter J. (2011). Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission. Journal of Occupational Medicine and Toxicology, 6(1), 2.
[18] Müller K, Valentine-Thon E. (2006). Hypersensitivity to titanium: clinical and laboratory evidence. Neuroendocrinology Letters, 27 Suppl 1, 31-35.
[19] Darbre PD. (2019). The history of endocrine-disrupting chemicals. Current Opinion in Endocrine and Metabolic Research, 7, 26-33.
[20] Steinemann A. (2016). Fragranced consumer products: exposures and effects from emissions. Air Quality, Atmosphere & Health, 9, 861-866.
[21] Trasande L, Shaffer RM, Sathyanarayana S, et al. (2018). Food additives and child health. Pediatrics, 142(2), e20181408.
[22] Mie A, Andersen HR, Gunnarsson S, et al. (2017). Human health implications of organic food and organic agriculture: a comprehensive review. Environmental Health, 16(1), 111.
[23] Salthammer T, Mentese S, Marutzky R. (2010). Formaldehyde in the indoor environment. Chemical Reviews, 110(4), 2536-2572.
[24] Allen JG, Gale S, Zoeller RT, et al. (2016). PBDE flame retardants, thyroid disease, and menopausal status in U.S. women. Environmental Health, 15, 60.
[25] Leung CC, Yu IT, Chen W. (2012). Silicosis. Lancet, 379(9830), 2008-2018.
[26] He C, Morawska L, Taplin L. (2007). Particle emission characteristics of office printers. Environmental Science & Technology, 41(17), 6039-6045.
[27] Daughton CG, Ruhoy IS. (2013). Lower-dose prescribing: minimizing “side effects” of pharmaceuticals on society and the environment. Science of the Total Environment, 443, 324-337.
[28] Münzel T, Sørensen M, Gori T, et al. (2022). Environmental stressors and cardio-metabolic disease: part I-epidemiologic evidence supporting a role for noise and air pollution and effects of mitigation strategies. European Heart Journal, 43(2), 122-132.
[29] Meyer JN, Leung MC, Rooney JP, et al. (2013). Mitochondria as a target of environmental toxicants. Toxicological Sciences, 134(1), 1-17.
[30] Naviaux RK. (2020). Perspective: cell danger response biology-the new science that connects environmental health with mitochondria and the rising tide of chronic illness. Mitochondrion, 51, 40-45.
[31] Filler K, Lyon D, Bennett J, et al. (2014). Association of mitochondrial dysfunction and fatigue: a review of the literature. BBA Clinical, 1, 12-23.
[32] Baccarelli A, Bollati V. (2009). Epigenetics and environmental chemicals. Current Opinion in Pediatrics, 21(2), 243-251.
[33] Hou L, Zhang X, Wang D, Baccarelli A. (2012). Environmental chemical exposures and human epigenetics. International Journal of Epidemiology, 41(1), 79-105..
[34] De Luca C, Scordo MG, Cesareo E, et al. (2010). Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. Toxicology and Applied Pharmacology, 248(3), 285-292.
[35] Randolph TG. (1990). Environmental medicine in the 21st century. Journal of Advancement in Medicine, 3(3), 149-153.
[36] Genuis SJ. (2011). Elimination of persistent toxicants from the human body. Human & Experimental Toxicology, 30(1), 3-18.
